Rob Howes

1.8k total citations
14 papers, 1.1k citations indexed

About

Rob Howes is a scholar working on Molecular Biology, Materials Chemistry and Oncology. According to data from OpenAlex, Rob Howes has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Materials Chemistry and 3 papers in Oncology. Recurrent topics in Rob Howes's work include Enzyme Structure and Function (4 papers), DNA Repair Mechanisms (3 papers) and Protein Structure and Dynamics (2 papers). Rob Howes is often cited by papers focused on Enzyme Structure and Function (4 papers), DNA Repair Mechanisms (3 papers) and Protein Structure and Dynamics (2 papers). Rob Howes collaborates with scholars based in United Kingdom, United States and Switzerland. Rob Howes's co-authors include Nicolas Foloppe, A.E. Surgenor, Alan Robertson, Andrew Potter, Geraint L. Francis, P. Dokurno, D.S. Williamson, James B. Murray, Jenifer Borgognoni and Martin J. Drysdale and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Genetics.

In The Last Decade

Rob Howes

14 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob Howes United Kingdom 13 578 420 154 121 118 14 1.1k
Nicole Caspers United States 15 490 0.8× 231 0.6× 116 0.8× 87 0.7× 113 1.0× 19 809
Matthew G. Bursavich United States 17 504 0.9× 379 0.9× 149 1.0× 122 1.0× 106 0.9× 29 904
Sang Min Lim South Korea 19 948 1.6× 385 0.9× 90 0.6× 82 0.7× 281 2.4× 50 1.5k
Andrew R. Bayly United Kingdom 4 694 1.2× 239 0.6× 132 0.9× 57 0.5× 129 1.1× 4 945
Ana Negri Spain 18 649 1.1× 146 0.3× 116 0.8× 79 0.7× 119 1.0× 31 1.1k
Charles L. Cywin United States 16 506 0.9× 573 1.4× 105 0.7× 67 0.6× 160 1.4× 26 1.1k
Bainan Wu United States 22 880 1.5× 150 0.4× 118 0.8× 102 0.8× 244 2.1× 28 1.2k
George Vielhauer United States 23 905 1.6× 304 0.7× 234 1.5× 136 1.1× 187 1.6× 33 1.4k
Laura Maccari Italy 16 337 0.6× 225 0.5× 117 0.8× 53 0.4× 119 1.0× 24 662
Valeria La Pietra Italy 22 557 1.0× 236 0.6× 118 0.8× 106 0.9× 281 2.4× 46 994

Countries citing papers authored by Rob Howes

Since Specialization
Citations

This map shows the geographic impact of Rob Howes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Howes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Howes more than expected).

Fields of papers citing papers by Rob Howes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Howes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Howes. The network helps show where Rob Howes may publish in the future.

Co-authorship network of co-authors of Rob Howes

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Howes. A scholar is included among the top collaborators of Rob Howes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Howes. Rob Howes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ding, Mei, Roger Clark, Catherine Bardelle, et al.. (2018). Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective. SLAS DISCOVERY. 23(7). 719–731. 12 indexed citations
2.
Naylor, Jacqueline, Arthur T. Suckow, David Baker, et al.. (2016). Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists. Biochemical Journal. 473(18). 2881–2891. 39 indexed citations
3.
Rossant, Christine, et al.. (2015). Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple Assays. SLAS DISCOVERY. 21(1). 24–34. 3 indexed citations
4.
Grassian, Alexandra, Fallon Lin, Rosemary Barrett, et al.. (2012). Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT). Journal of Biological Chemistry. 287(50). 42180–42194. 83 indexed citations
5.
Macias, Alba T., D.S. Williamson, Nicola J. Allen, et al.. (2011). Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity. Journal of Medicinal Chemistry. 54(12). 4034–4041. 88 indexed citations
6.
Williamson, D.S., Jenifer Borgognoni, Zoe Daniels, et al.. (2009). Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design. Journal of Medicinal Chemistry. 52(6). 1510–1513. 175 indexed citations
7.
Richardson, Christine M., D.S. Williamson, Martin J. Parratt, et al.. (2007). Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping. Bioorganic & Medicinal Chemistry Letters. 17(14). 3880–3885. 38 indexed citations
8.
Foloppe, Nicolas, et al.. (2006). Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening. Bioorganic & Medicinal Chemistry. 14(14). 4792–4802. 317 indexed citations
9.
Richardson, Christine M., D.S. Williamson, Martin J. Parratt, et al.. (2005). Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: Protein structure-guided design and SAR. Bioorganic & Medicinal Chemistry Letters. 16(5). 1353–1357. 56 indexed citations
10.
Povelones, Michael, Rob Howes, Matt Fish, & Roel Nusse. (2005). Genetic Evidence That Drosophila frizzled Controls Planar Cell Polarity and Armadillo Signaling by a Common Mechanism. Genetics. 171(4). 1643–1654. 25 indexed citations
11.
Williamson, D.S., Martin J. Parratt, Justin Bower, et al.. (2005). Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2. Bioorganic & Medicinal Chemistry Letters. 15(4). 863–867. 60 indexed citations
12.
Foloppe, Nicolas, et al.. (2005). Identification of a buried pocket for potent and selective inhibition of Chk1: Prediction and verification. Bioorganic & Medicinal Chemistry. 14(6). 1792–1804. 43 indexed citations
13.
Foloppe, Nicolas, et al.. (2005). Structure-Based Design of Novel Chk1 Inhibitors:  Insights into Hydrogen Bonding and Protein−Ligand Affinity. Journal of Medicinal Chemistry. 48(13). 4332–4345. 82 indexed citations
14.
Foloppe, Nicolas, et al.. (2004). A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site. Bioorganic & Medicinal Chemistry. 12(5). 935–947. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026